Further, BET protein inhibitors irreversibly suppressed the development of type I diabetes in NOD mice by promoting an anti-inflammatory phenotype in pancreatic macrophages, rather than infiltrating T cells, via modulation of the NFκB genes (54). The gene discussed is NFKB1; the disease is type 1 diabetes mellitus.